StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) stock

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.46−0.07 (-2.77%)

Close on Nov 17, 2026Market cap $2.46MP/E –Yield –

EoCene EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

EoCene's EPS for the twelve months ending Dec 31, 2025 was $19.12, down 70.4% year over year. For fiscal 2025 it was $19.12, down 70.4% from the year before. The highest annual figure on record is $1900.80 in fiscal 2021.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.12-70.4%
FY2024Dec 31, 2024$64.64-73.1%
FY2023Dec 31, 2023$240.00-76.5%
FY2022Dec 31, 2022$1022.40-46.2%
FY2021Dec 31, 2021$1900.80–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.86–
Q4 FY2025Dec 31, 2025-$6.41-134.7%
Q3 FY2025Sep 30, 2025$2.64-80.0%
Q2 FY2025Jun 30, 2025$5.06-94.5%
Q4 FY2024Dec 31, 2024-$15.97-107.4%
Q3 FY2024Sep 30, 2024$18.48-96.1%
Q2 FY2024Jun 30, 2024$13.20-96.5%
Q2 FY2023Jun 30, 2023$91.20-62.7%
Q2 FY2022Jun 30, 2022$216.00-31.8%
Q2 FY2021Jun 30, 2021$475.20–
Q2 FY2020Jun 30, 2020$374.40–
Q2 FY2018Jun 30, 2018$244.80–
Q2 FY2017Jun 30, 2017$316.80–

More EoCene figures

See a number that looks wrong?